The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Freiman Paul E. since 2009.
This trader's CIK number is 1410074.
At the time of last reporting, Freiman Paul E. was the Director of Novabay Pharmaceuticals, Inc.. (stock ticker symbol NBY).
Also see all insider trading activities at Novabay Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NBY | 0 | $0 | 0 | $0 | 858 | $0 |
| 2022 | NBY | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2011 | NBY | 3,000 | $2,520 | 0 | $0 | 0 | $0 |
| 2010 | NBY | 0 | $0 | 15,000 | $27,450 | 0 | $0 |
| 2009 | NBY | 0 | $0 | 25,000 | $58,250 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-11 | NBY | Option Ex | 858 | .00 | 0 |
| 2022-05-21 | NBY | Option Ex | 30,000 | .00 | 0 |
| 2011-09-12 | NBY | Buy | 3,000 | .84 | 2,520 |
| 2010-08-16 | NBY | Sale | 15,000 | 1.83 | 27,450 |
| 2009-06-11 | NBY | Sale | 25,000 | 2.33 | 58,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Freiman Paul E. (Director of Novabay Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.